Ulcerative Colitis Clinical Trials in Phoenix

Showing 501-520 of 587 trials

TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

NCT01294293

This phase I trial is studying the side effects and best dose of TLR8 agonist VTX-2337 and pegylated liposomal doxorubicin hydrochloride in treating patients with recurrent or persistent ovarian epithelial, fallopian tube, or peritoneal cavity cancer. Biological therapies, such as TLR8 agonist VTX-2337, may stimulate the immune system in different ways and stop tumor cells from growing. Drugs used in chemotherapy, such as pegylated liposomal doxorubicin hydrochloride and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving TLR8 agonist VTX-2337 together with pegylated liposomal doxorubicin hydrochloride or paclitaxel may kill more tumor cells.

Malignant Ovarian Mixed Epithelial TumorOvarian Brenner TumorOvarian Clear Cell Cystadenocarcinoma+7 more

Gynecologic Oncology Group20 participantsStarted Mar 2011

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Aurora, Colorado, United States +7 more locations

COMPLETEDPhase 3< 1 mile

Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®

NCT01696058

The overall objective of this study is to assess efficacy and safety of 12 weeks, once daily, orally inhaled co-administration of olodaterol 5 µg (delivered by the Respimat® Inhaler) and tiotropium (delivered by the Handihaler® as Spiriva Handihaler®), compared to tiotropium (Spiriva Handihaler®) monotherapy on lung function in patients with COPD.

Pulmonary Disease, Chronic Obstructive

Boehringer Ingelheim1,137 participantsStarted Sep 2012

Anniston, Alabama, United States • Birmingham, Alabama, United States • Mobile, Alabama, United States +91 more locations

TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®

Ulcerative Colitis Trials in Other Cities

Study of a Sleep Apnea System for the Treatment of Obstructive Sleep Apnea

Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery

NVA237 BID Versus Placebo Twelve-week Efficacy Study

Evaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy

Dose Ranging Study

Dose Ranging and Dose Frequency of LIPO-102

Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients

A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Comparing Two Pneumococcal Vaccines in Adults With Chronic Obstructive Pulmonary Disease

An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.

A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting

ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases

Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls

A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis

A Clinical Assessment Study of Subjects With Mucopolysaccharidosis IVA (Morquio Syndrome)

Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients

Improving Clinician Communication Skills (ICCS)

Other Conditions in Phoenix